BLEOMYCIN SULFATE Drug Patent Profile
✉ Email this page to a colleague
When do Bleomycin Sulfate patents expire, and what generic alternatives are available?
Bleomycin Sulfate is a drug marketed by Cipla, Fresenius Kabi Usa, Hikma, Hospira, Meitheal, Pharmachemie Bv, Teva Parenteral, and Teva Pharms Usa. and is included in eight NDAs.
The generic ingredient in BLEOMYCIN SULFATE is bleomycin sulfate. There are six drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the bleomycin sulfate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Bleomycin Sulfate
A generic version of BLEOMYCIN SULFATE was approved as bleomycin sulfate by HOSPIRA on March 10th, 2000.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for BLEOMYCIN SULFATE?
- What are the global sales for BLEOMYCIN SULFATE?
- What is Average Wholesale Price for BLEOMYCIN SULFATE?
Summary for BLEOMYCIN SULFATE
| US Patents: | 0 |
| Applicants: | 8 |
| NDAs: | 8 |
| Finished Product Suppliers / Packagers: | 6 |
| Raw Ingredient (Bulk) Api Vendors: | 55 |
| Clinical Trials: | 79 |
| Patent Applications: | 4,034 |
| DailyMed Link: | BLEOMYCIN SULFATE at DailyMed |
Recent Clinical Trials for BLEOMYCIN SULFATE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Jinnah Postgraduate Medical Centre | Phase 2 |
| The Emmes Company, LLC | Phase 1 |
| University of Arkansas | Phase 1 |
Pharmacology for BLEOMYCIN SULFATE
| Drug Class | Cytoprotective Agent |
Medical Subject Heading (MeSH) Categories for BLEOMYCIN SULFATE
Anatomical Therapeutic Chemical (ATC) Classes for BLEOMYCIN SULFATE
US Patents and Regulatory Information for BLEOMYCIN SULFATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cipla | BLEOMYCIN SULFATE | bleomycin sulfate | INJECTABLE;INJECTION | 209439-001 | Mar 11, 2019 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Hospira | BLEOMYCIN SULFATE | bleomycin sulfate | INJECTABLE;INJECTION | 065031-002 | Mar 10, 2000 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Hikma | BLEOMYCIN SULFATE | bleomycin sulfate | INJECTABLE;INJECTION | 065042-002 | Oct 17, 2001 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Teva Parenteral | BLEOMYCIN SULFATE | bleomycin sulfate | INJECTABLE;INJECTION | 064084-002 | Jun 1, 1996 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
